Session 61 - 12th CROI

Home

Session 61 Poster Abstracts
Pathogenesis: Host Genetic Studies
Thursday, 1:30 - 3:30 pm
Hall D

292	GNB3 C825T Polymorphism and Response to Antiretroviral Combination Therapy in HIV-1-infected Patients Norbert H Brockmeyer*¹, A Kasper¹, A Potthoff¹, R Schlottmann¹, C Nabring¹, K H Jöckel², and W Siffert² ¹Univ Clin St Josef Hosp, Bochum, Germany and ²Univ Clin of Essen, Germany
293	Population-specific Associations of CTLA4 Genotypes with HIV-1 Disease Progression Wenshuo Shao*¹, A Lazaryan¹, M Dorak¹, A Penman-Aguilar¹, C Wilson¹, J Margolick², J Goedert³, M Prins⁴, J Tang¹, R Kaslow¹, and for the MACS, DCG, REACH and ACS cohorts ¹Univ of Alabama at Birmingham, USA; ²Johns Hopkins Univ, Baltimore, MD, USA; ³NCI, NIH, DHHS, Bethesda, MD, USA; and ⁴Municipal Hlth Svc, Amsterdam, The Netherlands
294	Rare Allele Advantage: HIV-1-infected Adults Carrying Rare HLA Class I B Alleles Have Lower CD8+ T-cell Activation Levels Independent of HIV-1 RNA Level Jason Barbour*¹, M McGrath¹, J Oksenberg¹, and F Hecht¹ ¹Univ of California, San Francisco, USA
295	Genetic Correlates of Resistance to HIV Infection Mara Biasin*¹, G Magri¹, D Trabattoni¹, F Lissoni¹, Y Kanari², F Fasano¹, C Bergamaschi¹, L Piacentini¹, M Myazawa², and M Clerici¹ ¹Univ of Milan Sch of Med, Italy and ²Kinki Univ Sch of Med, Osaka, Japan
296	Differential Effects of Individual B58 Supertype Alleles on Control of HIV-1 Disease in Native Africans Aleksandr Lazaryan*¹, E Lobashevsky¹, J Mulenga², E Karita³, S Allen⁴, J Tang¹, and R Kaslow¹ ¹Univ of Alabama at Birmingham, USA; ²Natl Blood Transfusion Svc, Lusaka, Zambia; ³Project San Francisco, Kigali, Rwanda; and ⁴Emory Univ, Atlanta, GA, USA